Stocks and Investing
Stocks and Investing
Thu, November 9, 2023
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
[ 12:00 AM ] - WOPRAI
Boris Peaker Downgraded (ADCT) to Hold on, Nov 9th, 2023
Boris Peaker of TD Cowen, Downgraded "ADC Therapeutics SA" (ADCT) to Hold on, Nov 9th, 2023.
Boris has made no other calls on ADCT in the last 4 months.
There are 4 other peers that have a rating on ADCT. Out of the 4 peers that are also analyzing ADCT, 2 agree with Boris's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Cheng of "JP Morgan" Upgraded from Sell to Hold on, Thursday, August 10th, 2023
- Jeffrey Hung of "Morgan Stanley" Reiterated at Hold and Held Target at $5 on, Tuesday, July 11th, 2023
These are the ratings of the 2 analyists that currently disagree with Boris
- Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $6 on, Wednesday, November 8th, 2023
- Robert Burns of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $12 on, Tuesday, September 19th, 2023
Contributing Sources